InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Pinion John Richard, Executive. Insider active across 1 company, notably Ultragenyx Pharmaceutical Inc.. In total, 9 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €420k. Activity tracked since 6 May 2021. The latest transaction was disclosed on 16 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Pinion John Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
23,116 shares0Common StockSEC:0001193125-26-164289:0
11,137 shares0Common StockSEC:0001193125-26-089287:0
14,494 shares0Common StockSEC:0000950170-25-032785:0
17,800 shares0Common StockSEC:0000950170-24-026648:0
2,012 shares@ US$50.0019.5% of flowCommon StockSEC:0001209191-23-030931:0
2,663 shares0Common StockSEC:0001209191-23-016042:0
4,498 shares@ US$66.620.011% mcap69.3% of flowCommon StockSEC:0001209191-22-015823:0
358 shares@ US$81.146.0% of flowCommon StockSEC:0001209191-21-060748:0
363 shares@ US$113.698.1% of flowCommon StockSEC:0001209191-21-031387:0
9 of 9 declarations
About Pinion John Richard
John Richard Pinion is a key member of Ultragenyx Pharmaceutical Inc. While his specific role is not detailed, he contributes to the management and strategy of the company. His expertise in the pharmaceutical sector is essential for guiding strategic decisions and optimizing performance.
